Merck and Huma Therapeutics launch innovative app to support bladder cancer patients
Posted:
London headquartered Huma Therapeutics, together with Germany's Merck KGaA, has announced the launch of their innovative bladder cancer treatment companion app in the United Kingdom.
Generative AI voice agents—conversational systems powered by large language models that can understand and produce natural speech in real time—are poised to transform how health systems engage with patients.
Read more here.
Stanford Medicine researchers developed a way to create the first heart and liver organoids that generate their own blood vessels, possibly paving the way for organoid-based regenerative therapies.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us